Recruiting

Exoskeleton

Sponsor:

Wandercraft

Code:

NCT06777576

Conditions

Spinal Cord Injuries (SCI)

Paraplegia and Tetraplegia

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Accepted

Interventions

Hands-free exoskeleton

Study Details

Brief summary:

This study aims to demonstrate the safety and effectiveness of the personal exoskeleton in individuals with spinal cord injury (SCI).

Conditions

Spinal Cord Injuries (SCI)

Paraplegia and Tetraplegia

Study ID

NCT06777576

Start date

Feb 12, 2025

Status verified date

Jan, 2026

Completion date

May 31, 2026

Anticipated

Primary completion date

May 31, 2026

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Accepted

SCI user inclusion Criteria:

  • Any gender, age 18 years or older;
  • Motor complete or incomplete SCI with lesions at or above T6;
  • ≥ 6 months post SCI;
  • Able and willing to attend 9 to 10 visits1 to the center, including sessions of training and assessments of one-to-three hours duration;
  • Able to read, understand, and provide informed consent;
  • Living in the US and speaks English.

SCI user exclusion Criteria:

  • Diagnosis of neurological injury other than SCI;
  • Progressive condition that would be expected to result in changing neurological status;
  • Severe concurrent medical disease, illness or condition judged to be contraindicated by the site physician;
  • Unhealed or unstable traumatic or high impact lower extremity fracture of any duration that is, in the clinical judgement of the study physician, exclusionary for standing and walking;
  • Knee (proximal tibia and/or distal femur) BMD <0.60 gm/cm2;
  • Total hip BMD T-scores < -3.5;
  • Fragility, minimal trauma, or low impact fracture of the lower extremity since SCI;
  • Untreatable severe spasticity judged to be contraindicated by the site physician;
  • Untreated/uncontrolled hypertension, as judged to be contraindicated by the site physician;
  • Unresolved orthostatic hypotension (change from baseline seated BP to a fall in 20mmHg SBP and/or fall in 10mmHG DBP and symptoms when standing), or as judged to be contraindicated by the site physician;
  • Open or unhealed skin pressure sores, abrasions, or bruises at any of the contact points of the exoskeleton;
  • Morphological contraindications to the use of the device;
  • Uncorrectable leg length discrepancy over 2 cm (about 0.79 in) when using additional correction tools;
  • Unable to effectively operate the device with a hand-control interface, due to functional and/or cognitive impairment, evaluated based on the ability to manipulate the joystick in all direction, press and identify buttons on the hand control interface.
  • Improper fitting in the device;
  • Psychopathology documentation in the medical record that may conflict with study objectives;
  • Pregnancy or women who plan to become pregnant during the study period;
  • Concurrent participation in another interventional trial;
  • History of uncontrolled autonomic dysreflexia;
  • Presence colostomy and/or urostomy;
  • Ventilator use at the time of the exoskeleton use.

Companion inclusion Criteria:

  • Any gender, age 18 years or older;
  • Willingness to attend 9 to 10 visits to the center, including sessions of training and assessments of one-to-three hours duration with the SCI user;
  • Able to read, understand and provide informed consent;
  • Living in the US and speaks English.

Companion exclusion Criteria:

  • Inability to communicate with an assistant due to cognitive and language disorders;
  • Any disease, concomitant injury, or condition that interferes with the performance or interpretation of the protocol- specified assessments;
  • Insufficient strength and performance capability, evidenced by the ability to hold and retain the device in case of unbalance/fall;
  • Insufficient availability to complete the study;
  • Concurrent participation in another interventional trial.

Study Design

Enrollment

24 participants

Anticipated

Intervention Model

Single group

Primary purpose

Other

Interventions and Outcome Measures

Arms

experimental: Hands-free exoskeleton

Interventions

Hands-free exoskeleton

A "device trainer specialist" from the investigation site will deliver training sessions with the exoskeleton to pair of participants (a pair corresponds to an individual with SCI and his/her companion). The device trainer will follow the progression of the pair through the training program and ensure they learn all the device "basic skills". Each training session lasts an average of 1.5 hours, variations according to the user's learning pace and tolerance. During the sessions with the exoskeleton, the participants will engage in mobility activities on different surfaces and perform Activities of Daily Living in simulated environments such as kitchen, bathroom, elevators and outdoor spaces.

Primary outcome measure

  • Proportion of subjects who complete the Timed Up and Go (TUG) in 3min or less. [ Time Frame: At visit 7, after an average of 7.5 hours of training and at visit 9, after an average of 9 hours of training. ]
  • Proportion of subjects who complete a distance of at least 40m on the Six-Minute Walk Test (6MWT). [ Time Frame: At visit 7, after an average of 7.5 hours of training and at visit 9, after an average of 9 hours of training. ]

Central Contacts and Locations

Central contacts

Locations

James J. Peters, VA Medical Center, Bronx, NY

Recruiting

The Bronx, New York, United States, 10468-3904

Contacts

Principal Investigator:

Ann M Spungen, EdD

More Information

Sponsor

Wandercraft

Last update posted

Feb 2, 2026

Last verified

Jan, 2026

Keywords

  • Spinal Cord Injury
  • Robotics
  • Community use
  • Hands-free exoskeleton
  • Overground exoskeleton
  • Walking
  • Self-balancing

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Wandercraft on 2026-02-02.